Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-26
2006-09-26
Jiang, Shaojia A. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S264100, C514S266220, C514S266230, C514S300000, C514S301000, C514S302000, C514S115000, C544S279000, C544S284000, C546S114000, C548S152000, C548S217000, C548S304700, C548S360100
Reexamination Certificate
active
07112590
ABSTRACT:
The invention relates to compounds that are heterocyclic derivatives of dipeptides and dipeptides mimetics and pharmaceutically acceptable salts thereof. The compounds are used as thrombin inhibitors
REFERENCES:
patent: 5510369 (1996-04-01), Lumma et al.
patent: 5523308 (1996-06-01), Costanzo et al.
patent: 5811402 (1998-09-01), Klimkowski et al.
patent: 5827866 (1998-10-01), Costanzo et al.
patent: WO 98/47876 (1998-10-01), None
Das J et al. “Thrombin Active Site Inhibitors”, Bioorganic & Medicinal Chemistry, GB, Elsevier Science Ltd, vol. 3, No. 8, 1995, pp. 999-1007, XP000995766.
International Search Report, Jul. 9, 2001.
Breznik Matej
Fortuna Marjana
Kikelj Danijel
Marinko Petra
Peterlin Lucija
Bromberg & Sunstein LLP
Jiang Shaojia A.
Krishnan Ganapathy
LEK Pharmaceuticals d.d.
University of Ljubljana, Faculty of Pharmacy
LandOfFree
Thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3567326